Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 927-786-6 | CAS number: 1180051-47-1
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Acide ioxaglique 286
- IUPAC Name:
- Acide ioxaglique 286
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- "286 intermediate" is the precursor of the compound "286" known as "ioxaglic acid". "286 intermediate"and "286" have the same chemical struture except that "286 intermediate" is the triethylammonium salt of "286". "286intermediate" can have a slightly higher impurity content (less than 2% with no impurity detected above 1%) than 286. It is not believed that these minor differences may alter dramatically the toxicity profile established for "286". It is also of importance to know that "286" is a well-characterized pharmaceutical active substance, authorised in drug product called Hexabrix.
Therefore, the data on "286" are considered fully relevant to assess the toxicity profile of "286 intermediate".
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 2000 mg/kg at 5 ml/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortality observed after 14d
- Clinical signs:
- other: no clinical signs observed after 14d
- Gross pathology:
- No gross pathology observed after 14d.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Upon directive 67/548, substance is not classified as dangerous.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
